Curriculum Vitaes
Profile Information
- Affiliation
- Professor, Fujita Health University
- Degree
- PhD(Mar, 1996, Kyoto University)
- J-GLOBAL ID
- 201401018385439878
- researchmap Member ID
- 7000008580
- External link
Research Interests
7Research Areas
5Research History
8Education
3Committee Memberships
5-
2019 - Present
-
2014 - Present
-
2014 - 2019
-
2016 - 2018
-
2012 - 2018
Papers
83-
Journal of Biological Chemistry, 107630-107630, Aug, 2024
-
Glycoconjugate journal, 40(2) 225-246, Apr, 2023CD22, one of the sialic acid-binding immunoglobulin-like lectins (Siglecs), regulates B lymphocyte signaling via its interaction with glycan ligands bearing the sequence Neu5Ac/Gcα(2→6)Gal. We have developed the synthetic sialoside GSC-718 as a ligand mimic for CD22 and identified it as a potent CD22 inhibitor. Although the synthesis of CD22-binding sialosides including GSC-718 has been reported by our group, the synthetic route was unfortunately not suitable for large-scale synthesis. In this study, we developed an improved scalable synthetic procedure for sialosides which utilized 1,5-lactam formation as a key step. The improved procedure yielded sialosides incorporating a series of aglycones at the C2 position. Several derivatives with substituted benzyl residues as aglycones were found to bind to mouse CD22 with affinity comparable to that of GSC-718. The new procedure developed in this study affords sialosides in sufficient quantities for cell-based assays, and will facilitate the search for promising CD22 inhibitors that have therapeutic potential.
-
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 37(1) e22680, Jan, 2023Spermatid production is a complex regulatory process in which coordination between hormonal control and apoptosis plays a pivotal role in maintaining a balanced number of sperm cells. Apoptosis in spermatogenesis is controlled by pro-apoptotic and anti-apoptotic molecules. Hormones involved in the apoptotic process during spermatogenesis include gonadotrophins, sex hormones, and glucocorticoid (GC). GC acts broadly as an apoptosis inducer by binding to its receptor (glucocorticoid receptor: GR) during organ development processes, such as spermatogenesis. However, the downstream pathway induced in GC-GR signaling and the apoptotic process during spermatogenesis remains poorly understood. We reported previously that GC induces full-length glucocorticoid-induced transcript 1 (GLCCI1-long), which functions as an anti-apoptotic mediator in thymic T cell development. Here, we demonstrate that mature murine testis expresses a novel isoform of GLCCI1 protein (GLCCI1-short) in addition to GLCCI1-long. We demonstrate that GLCCI1-long is expressed in spermatocytes along with GR. In contrast, GLCCI1-short is primarily expressed in spermatids where GR is absent; instead, the estrogen receptor is expressed. GLCCI1-short also binds to LC8, which is a known mediator of the anti-apoptotic effect of GLCCI1-long. A luciferase reporter assay revealed that β-estradiol treatment synergistically increased Glcci1-short promotor-driven luciferase activity in Erα-overexpressing cells. Together with the evidence that the conversion of testosterone to estrogen is preceded by aromatase expression in spermatids, we hypothesize that estrogen induces GLCCI1-short, which, in turn, may function as a novel anti-apoptotic mediator in mature murine testis.
-
Journal of the American Society of Nephrology : JASN, 33(11) 2008-2025, Nov, 2022BACKGROUND: The cause of podocyte injury in idiopathic nephrotic syndrome (INS) remains unknown. Although recent evidence points to the role of B cells and autoimmunity, the lack of animal models mediated by autoimmunity limits further research. We aimed to establish a mouse model mimicking human INS by immunizing mice with Crb2, a transmembrane protein expressed at the podocyte foot process. METHODS: C3H/HeN mice were immunized with the recombinant extracellular domain of mouse Crb2. Serum anti-Crb2 antibody, urine protein-to-creatinine ratio, and kidney histology were studied. For signaling studies, a Crb2-expressing mouse podocyte line was incubated with anti-Crb2 antibody. RESULTS: Serum anti-Crb2 autoantibodies and significant proteinuria were detected 4 weeks after the first immunization. The proteinuria reached nephrotic range at 9-13 weeks and persisted up to 29 weeks. Initial kidney histology resembled minimal change disease in humans, and immunofluorescence staining showed delicate punctate IgG staining in the glomerulus, which colocalized with Crb2 at the podocyte foot process. A subset of mice developed features resembling FSGS after 18 weeks. In glomeruli of immunized mice and in Crb2-expressing podocytes incubated with anti-Crb2 antibody, phosphorylation of ezrin, which connects Crb2 to the cytoskeleton, increased, accompanied by altered Crb2 localization and actin distribution. CONCLUSION: The results highlight the causative role of anti-Crb2 autoantibody in podocyte injury in mice. Crb2 immunization could be a useful model to study the immunologic pathogenesis of human INS, and may support the role of autoimmunity against podocyte proteins in INS.
-
Biochemical and biophysical research communications, 614 198-206, Jul 23, 2022Podocyte damage is a major pathological lesion leading to focal segmental glomerulosclerosis (FSGS). Podocytes damaged by cellular stress undergo hypertrophy to compensate for podocytopenia. It is known that cyclin-dependent kinase inhibitors induced by p53 ensure podocytes hypertrophy; however, its precise mechanism remains to be further investigated. In this study, we found that ubiquitin specific protease 40 (USP40) is a novel regulator of p53. Although USP40 knockout mice established in the present study revealed no abnormal kidney phenotype, intermediate filament Nestin was upregulated in the glomeruli, and was bound to and colocalized with USP40. We also found that USP40 deubiquitinated histidine triad nucleotide-binding protein 1 (HINT1), an inducer of p53. Gene knockdown experiments of USP40 in cultured podocytes revealed the reduction of HINT1 and p53 protein expression. Finally, in glomerular podocytes of mouse FSGS, upregulation of HINT1 occurred in advance of the proteinuria, which was followed by upregulation of USP40, p53 and Nestin. In conclusion, USP40 bound to Nestin deubiquitinates HINT1, and in consequence upregulates p53. These results provide additional insight into the pathological mechanism of podocyte hypertrophy in FSGS.
Misc.
54-
Viruses, 13(5) 815-815, May 1, 2021 Peer-reviewedThe first step in influenza virus infection is the binding of hemagglutinin to sialic acid-containing glycans present on the cell surface. Over 50 different sialic acid modifications are known, of which N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) are the two main species. Animal models with α2,6 linked Neu5Ac in the upper respiratory tract, similar to humans, are preferred to enable and mimic infection with unadapted human influenza A viruses. Animal models that are currently most often used to study human influenza are mice and ferrets. Additionally, guinea pigs, cotton rats, Syrian hamsters, tree shrews, domestic swine, and non-human primates (macaques and marmosets) are discussed. The presence of NeuGc and the distribution of sialic acid linkages in the most commonly used models is summarized and experimentally determined. We also evaluated the role of Neu5Gc in infection using Neu5Gc binding viruses and cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH)−/− knockout mice, which lack Neu5Gc and concluded that Neu5Gc is unlikely to be a decoy receptor. This article provides a base for choosing an appropriate animal model. Although mice are one of the most favored models, they are hardly naturally susceptible to infection with human influenza viruses, possibly because they express mainly α2,3 linked sialic acids with both Neu5Ac and Neu5Gc modifications. We suggest using ferrets, which resemble humans closely in the sialic acid content, both in the linkages and the lack of Neu5Gc, lung organization, susceptibility, and disease pathogenesis.
-
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1861(10) 2455-2461, Oct, 2017 Peer-reviewedBackground: The human natural killer-1 (HNK-1) carbohydrate, a unique trisaccharide possessing sulfated glucuronic acid in a non-reducing terminus (HSO3-3G1cA beta 1-3Galf beta-4G1cNAc-), is highly expressed in the nervous system and its spatiotemporal expression is strictly regulated. Mice deficient in the gene encoding a key enzyme, GIcAT-P, of the HNK-1 biosynthetic pathway exhibit almost complete disappearance of the HNK-1 epitope in the brain, significant reduction of long-term potentiation, and aberration of spatial learning and memory formation. In addition to its physiological roles in higher brain function, the HNK-1 carbohydrate has attracted considerable attention as an autoantigen associated with peripheral demyelinative neuropathy, which relates to IgM paraproteinemia, because of high immunogenicity. It has been suggested, however, that serum autoantibodies in IgM anti-myelin-associated glycoprotein (MAG) antibody-associated neuropathy patients show heterogeneous reactivity to the HNK-1 epitope. Scope of review: We have found that structurally distinct HNK-1 epitopes are expressed in specific proteins in the nervous system. Here, we overview the current knowledge of the involvement of these HNK-1 epitopes in the regulation of neural plasticity and discuss the impact of different HNK-1 antigens of anti-MAG neuropathy patients. Major conclusions: We identified the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptor subunit GluA2 and aggrecan as HNK-1 carrier proteins. The HNK-1 epitope on GluA2 and aggrecan regulates neural plasticity in different ways. Furthermore, we found the clinical relationship between reactivity of autoantibodies to the different HNK-1 epitopes and progression of anti-MAG neuropathy. General significance: The HNK-1 epitope is indispensable for the acquisition of normal neuronal function and can be a good target for the establishment of diagnostic criteria for anti-MAG neuropathy.
-
日本生化学会大会プログラム・講演要旨集, 89回 [2T08-02(2P, Sep, 2016
-
日本生化学会大会・日本分子生物学会年会合同大会講演要旨集, 88回・38回 [4W16-p, Dec, 2015
-
日本生化学会大会・日本分子生物学会年会合同大会講演要旨集, 88回・38回 [2P0265]-[2P0265], Dec, 2015
-
GLYCOBIOLOGY, 24(11) 1156-1157, Nov, 2014
-
GLYCOBIOLOGY, 24(11) 1154-1154, Nov, 2014
-
GLYCOBIOLOGY, 24(11) 1091-1092, Nov, 2014
-
GLYCOBIOLOGY, 24(11) 1147-1147, Nov, 2014
-
GLYCOBIOLOGY, 24(11) 1110-1111, Nov, 2014
-
FASEB JOURNAL, 28(1), Apr, 2014
-
Methods in Molecular Biology, 1200 379-387, 2014 Peer-reviewedRemodeling of glycans on the cell surface is an essential technique to analyze cellular function of lectin-glycan ligand interaction. Here we describe the methods to identify the responsible enzyme (glycosyltransferase) regulating the expression of the glycan of interest and to modulate the glycan expression by overexpressing the glycosyltransferase gene. For the identification of the responsible enzyme, we introduce a new method, CIRES (correlation index-based responsible-enzyme gene screening), that consists of statistical comparison of glycan expression profile obtained by flow cytometry and gene expression profile obtained by DNA microarray. © 2014 Springer Science+Business Media New York.
-
Regulatory Functions of Activation-Dependent Reduction of N-glycolylneuraminic Acid in Mouse T CellsGLYCOBIOLOGY, 21(11) 1479-1480, Nov, 2011
-
GLYCOBIOLOGY, 20(11) 1455-1455, Nov, 2010
-
Seikagaku, 82(8) 735-740, 2010 Peer-reviewed
-
Clinical immunology & allergology, 52(5) 561-570, Nov, 2009
-
CHEMISTRY AND PHYSICS OF LIPIDS, 160 S30-S30, Aug, 2009
-
AMERICAN JOURNAL OF TRANSPLANTATION, 9 381-381, 2009
-
AMERICAN JOURNAL OF TRANSPLANTATION, 9 469-470, 2009
-
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 54(15) 1972-1979, 2009 Peer-reviewed
-
GLYCOBIOLOGY, 18(11) 957-957, Nov, 2008
-
GLYCOBIOLOGY, 18(11) 989-989, Nov, 2008
-
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 53(12 Suppl) 1630-1635, Sep, 2008 Peer-reviewed
-
CHEMISTRY AND PHYSICS OF LIPIDS, 154 S13-S13, Aug, 2008
-
Cell technology., 26(6) 640-643, Jun, 2007
-
脂質生化学研究, 49 116-116, May 20, 2007糖脂質の発現制御の解析には多数の遺伝子を網羅的に解析可能なDNAマイクロアレイによる解析が非常に有用である。当研究室で、糖・脂質関連酵素を中心にしたDNAマイクロアレイを作成し、多くのサンプルについて糖脂質関連遺伝子の発現パターンの解析を行ってきた。今回、DNAマイクロアレイの新たな解析方法論の開発を試み、糖脂質の発現制御に関わる候補遺伝子を確からしさの順位とともに提示できるシステムを開発した。(著者抄録)
-
GLYCOBIOLOGY, 16(11) 1134-1134, Nov, 2006
-
GLYCOBIOLOGY, 14(11) 1146-1146, Nov, 2004
-
GLYCOBIOLOGY, 14(11) 1201-1201, Nov, 2004
-
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 48(8 Suppl) 947-951, 2003 Peer-reviewed
-
脂質生化学研究, 44 29-29, Jun 14, 2002
-
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1582(1-3) 138-143, May, 2002 Peer-reviewedIn this review, we focus on sphingolipids as potential regulators of the induction of multinuclear cell formation through the inhibition of cytokinesis. A sphingolipid, psychosine (Psy) (galactosylsphingosine), was demonstrated to be a trigger lipid for the inhibition of cytokinesis and the induction of multinuclear giant cells associated with a sphingolipid metabolic disease, globoid cell leukodystrophy (GLD). Indeed, Psy is known to accumulate in the patients' brains. Interestingly, inhibition of sphingolipid biosynthesis also induced multinuclear cells. When cells were treated with a new immunosuppressant, ISP-1/myriocin, which inhibits serine palmitoyltransferase, the first step enzyme of sphingolipid biosynthesis, the cells underwent multinucleation and apoptosis. At present, a definitive model of the function of sphingolipids as to the induction of multinuclear cell formation is not available due to the rudimentary information but possible mechanisms are discussed. (C) 2002 Elsevier Science B.V. All rights reserved.
-
MOLECULAR BIOLOGY OF THE CELL, 11 135A-136A, Dec, 2000
Professional Memberships
6Research Projects
11-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2021 - Mar, 2024
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2020 - Mar, 2022
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2016 - Mar, 2018
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2014 - Mar, 2017
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2011 - Mar, 2016